Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0376358 (
prostate cancer
)
59,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Ca(2+)-permeable channel
TRPM8
is thought to play an important role in the pathophysiology of
prostate cancer
. We have investigated the intracellular location of
TRPM8
and its role as a Ca(2+)-permeable channel in an androgen-responsive and an androgen-insensitive
prostate cancer
cell line. We report evidence from immunofluorescence experiments that in the androgen-responsive LNCaP cell line, the TRPM8 protein is expressed in the endoplasmic reticulum and plasma membrane, acts as a Ca(2+)-permeable channel (assessed using Fura-2 to measure increases in the cytoplasmic Ca(2+) concentration) in each of these membranes, and is regulated by androgen. Although
TRPM8
was detected in the androgen-insensitive PC-3 cell line, no evidence was obtained for regulation of its expression by androgen. The results of experiments using LNCaP cells, the
TRPM8
antagonist capsazepine, and small interference RNA targeted to
TRPM8
indicate that
TRPM8
is required for cell survival. These results indicate that
TRPM8
is an important determinator of Ca(2+) homeostasis in prostate epithelial cells and may be a potential target for the action of drugs in the management of
prostate cancer
.
...
PMID:Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. 1554 6
TRPM8
(melastatine-related transient receptor potential member 8), a member of the transient receptor potential (TRP) superfamily of cation channels, has been shown to be a calcium-channel protein.
TRPM8
mRNA has also been shown to be overexpressed in
prostate cancer
and is considered to play an important role in prostate physiology. This study was designed to determine the androgen-regulation mechanisms for
TRPM8
mRNA expression and to identify the phenotype of
TRPM8
-expressing cells in the human prostate. Our findings show that trpm8 gene expression requires a functional androgen receptor. Furthermore, this article argues strongly in favour of the fact that the trpm8 gene is a primary androgen-responsive gene. Single-cell reverse transcriptase PCR and immunohistochemical experiments also showed that the trpm8 gene was mainly expressed in the apical secretory epithelial cells of the human prostate and trpm8 down-regulation occurred during the loss of the apical differentiated phenotype of the primary cultured human prostate epithelial cells. The androgen-regulated trpm8 expression mechanisms are important in understanding the progression of
prostate cancer
to androgen-independence. These findings may contribute to design a strategy to predict
prostate cancer
status from the
TRPM8
mRNA level. Furthermore, as the
TRPM8
channel is localized in human prostate cells, it will be interesting to understand its physiological function in the normal prostate and its potential role in
prostate cancer
development.
...
PMID:Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. 1594 9
Recent cloning of a cold/menthol-sensitive
TRPM8
channel (transient receptor potential melastatine family member 8) from rodent sensory neurons has provided the molecular basis for the cold sensation. Surprisingly, the human orthologue of rodent
TRPM8
also appears to be strongly expressed in the prostate and in the
prostate cancer
-derived epithelial cell line, LNCaP. In this study, we show that despite such expression, LNCaP cells respond to cold/menthol stimulus by membrane current (I(cold/menthol)) that shows inward rectification and high Ca(2+) selectivity, which are dramatically different properties from "classical"
TRPM8
-mediated I(cold/menthol). Yet, silencing of endogenous
TRPM8
mRNA by either antisense or siRNA strategies suppresses both I(cold/menthol) and TRPM8 protein in LNCaP cells. We demonstrate that these puzzling results arise from
TRPM8
localization not in the plasma, but in the endoplasmic reticulum (ER) membrane of LNCaP cells, where it supports cold/menthol/icilin-induced Ca(2+) release from the ER with concomitant activation of plasma membrane (PM) store-operated channels (SOC). In contrast, GFP-tagged
TRPM8
heterologously expressed in HEK-293 cells target the PM. We also demonstrate that
TRPM8
expression and the magnitude of SOC current associated with it are androgen-dependent. Our results suggest that the
TRPM8
may be an important new ER Ca(2+) release channel, potentially involved in a number of Ca(2+)- and store-dependent processes in
prostate cancer
epithelial cells, including those that are important for prostate carcinogenesis, such as proliferation and apoptosis.
...
PMID:Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells. 1617 75
During the past 5 years it has emerged that the transient receptor potential (TRP) family of Ca(2+)-and Na(+)-permeable channels plays a diverse and important role in cell biology and in pathology. One member of this family,
TRPM8
, is highly expressed in
prostate cancer
cells but the physiological and pathological functions of
TRPM8
in these cells are not known. Here we address these questions, and the issue of whether or not
TRPM8
is an effective diagnostic and prognostic marker in
prostate cancer
.
TRPM8
is known to be activated by cool stimuli (17-25 degrees C) and cooling compounds such as menthol. The activation mechanism(s) involves voltage sensing of membrane potential, phosphatidylinositol 4,5-bisphosphate and Ca(2+). In addition to
prostate cancer
cells,
TRPM8
is expressed in sensory neurons where it acts as a sensor of cold. In prostate epithelial cells, expression of
TRPM8
is regulated by androgen and is elevated in androgen-sensitive cancerous cells compared with normal cells. While there is some evidence that in
prostate cancer
cells Ca(2+) and Na(+) inflow through
TRPM8
is necessary for survival and function, including secretion at the apical membrane, the function of
TRPM8
in these cells is not really known. It may well differ from the role of
TRPM8
as a cool sensor in sensory nerve cells. Androgen unresponsive
prostate cancer
is difficult to treat effectively and there are limited diagnostic and prognostic markers available.
TRPM8
is a potential tissue marker in differential diagnosis and a potential prognostic marker for androgen-unresponsive and metastatic
prostate cancer
. As a consequence of its ability to convey Ca(2+) and Na(+) and its expression in only a limited number of cell types,
TRPM8
is considered to be a promising target for pharmaceutical, immunological and genetic interventions for the treatment of
prostate cancer
.
...
PMID:TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? 1660 Dec 77
Some proteins of the transient receptor potential (TRP) family form temperature sensitive ion channels. One member of the melastatin (M) group, namely
TRPM8
is activated by cold and cooling compounds such as menthol and icilin, and its gene is up-regulated in
prostate cancer
and other malignancies. Here we characterise the effects of the carboxamides WS-12, CPS-113, CPS-369, the carboxylic acid WS-30 and the phosphine oxide WS-148 by Ca2+ imaging experiments and whole-cell patch-clamp recordings on
TRPM8
expressing human embryonic kidney (HEK), lymph node
prostate cancer
(LNCaP) and dorsal root ganglia (DRG) cells. The cooling compounds introduced in this study, show a dose-dependent and reversible activation of
TRPM8
with EC50 values in the nM to low microM range. The carboxamide WS-12 is most potent in activating
TRPM8
. It is selective, since other TRP proteins are not stimulated at muM concentrations and its efficacy with respect to
TRPM8
is similar to the one of icilin. In summary, the compounds described in this study represent new tools to dissect
TRPM8
functions and may serve as chemical leads for the development of additional
TRPM8
agonists and novel antagonists. Such compounds may be beneficial for preventing noxious cold perception. They could also be useful in diagnosis and treatment of most common cancers in which the
TRPM8
gene is up-regulated in comparison to the corresponding normal tissue.
...
PMID:Characterisation of TRPM8 as a pharmacophore receptor. 1751 34
The progression of cells from a normal differentiated state in which rates of proliferation and apoptosis are balanced to a tumorigenic and metastatic state involves the accumulation of mutations in multiple key signalling proteins and the evolution and clonal selection of more aggressive cell phenotypes. These events are associated with changes in the expression of numerous other proteins. This process of tumorigenesis involves the altered expression of one or more TRP proteins, depending on the nature of the cancer. The most clearly described changes are those involving
TRPM8
, TRPV6 and TRPM1. Expression of
TRPM8
is substantially increased in androgen-dependent
prostate cancer
cells, but is decreased in androgen independent and metastatic
prostate cancer
.
TRPM8
expression is regulated, in part, by androgens, most likely through androgen response elements in the
TRPM8
promoter region.
TRPM8
channels are involved in the regulation of cell proliferation and apoptosis. Expression of TRPV6 is also increased in
prostate cancer
and in a number of other cancers. In contrast to
TRPM8
, expression of TRPV6 is not directly regulated by androgens. TRPM1 is highly expressed in early stage melanomas but its expression declines with increases in the degree of aggressiveness of the melanoma. The expression of TRPV1, TRPC1, TRPC6, TRPM4, and TRPM5 is also increased in some cancers. The level of expression of
TRPM8
and TRPV6 in
prostate cancer
, and of TRPM1 in melanomas, potentially provides a good prognostic marker for predicting the course of the cancer in individuals. The Drosophila melanogaster, TRPL, and the TRPV1 and
TRPM8
proteins, have been used to try to develop strategies to selectively kill cancer cells by activating Ca(2+) and Na(+) entry, producing a sustained increase in the cytoplasmic concentration of these ions, and subsequent cell death by apoptosis and necrosis. TRPV1 is expressed in neurones involved in sensing cancer pain, and is a potential target for pharmacological inhibition of cancer pain in bone metastases, pancreatic cancer and most likely in other cancers. Further studies are required to assess which other TRP proteins are associated with the development and progression of cancer, what roles TRP proteins play in this process, and to develop further knowledge of TRP proteins as targets for pharmaceutical intervention and targeting in cancer.
...
PMID:TRP channels in cancer. 1761 60
Selected transcript markers as well as their combinations were analyzed on minimal prostate tissue specimens with regard to their diagnostic potential. Artificial prostate biopsies from RPE explants were used for evaluation and optimization of the techniques used followed by application to diagnostic prostate needle core biopsies. Minimal prostate specimens were cryopreserved and processed with standardized methods. The RNA amount of a half of each biopsy was sufficient for the analysis of 11 marker genes and one reference gene (TBP) using quantitative PCR assays.The relative transcript amounts obtained were included in several analyses including calculations for each single marker gene like median overexpression rate as well as marker combinations. Two optimized mathematical models based on relative expression levels of EZH2, hepsin, PCA3, prostein, and
TRPM8
were evaluated with regard to their diagnostic potential. Compared to single marker analyses these models show higher sensitivity and specificity for
prostate cancer
detection.Thus biomolecular
prostate cancer
identification may represent a suitable diagnostic tool to supplement conventional techniques on prostate biopsies. Furthermore, an extension of this approach to PCa prognosis and the transfer to urine samples appear very promising.
...
PMID:[Molecular genetic markers for prostate cancer. Evidence in fine needle biopsies for improved confirmation of the diagnosis]. 1867 47
Menthol, a naturally occurring compound from peppermint oil, binds and activates the
TRPM8
Ca(2+)-permeable channel that exhibits abnormal expression patterns in
prostate cancer
, suggesting that
TRPM8
links Ca(2+) transport pathways to tumor biology. We thus investigated the cellular responses of
prostate cancer
cells to menthol. Here we found that menthol increases [Ca(2+)](i) via Ca(2+) influx mechanism(s) independent of
TRPM8
in PC-3 cells. We demonstrated that menthol induces cell death at supramillimolar concentrations in PC-3 cells and the cell death is not suppressed by low extracellular Ca(2+) condition which indicates that menthol-induced cell death is not associated with Ca(2+) influx pathways. In addition, we showed that menthol increases a phosphorylated form of c-jun N-terminal kinase (JNK) in PC-3 cells through
TRPM8
-independent mechanisms. Thus, our data indicate that there is an apparent lack of causality between
TRPM8
activation and menthol-induced cell death and that menthol can regulate
TRPM8
-independent Ca(2+)-transport and cellular processes.
...
PMID:Menthol regulates TRPM8-independent processes in PC-3 prostate cancer cells. 1895 32
Identification of sensitive and specific biomarkers for early detection and prognosis of
prostate cancer
is essential for timely and appropriate treatment of the disease in individual patients. We identified an RNA transcript with sequence homology to
TRPM8
(melastatin-related transient receptor potential member 8) that was overexpressed in tumor vs. patient-matched non-tumor prostate tissues by RT-PCR differential display (DD). Semi-quantitative RT-PCR analysis revealed that
TRPM8
levels were higher in tumor than in non-tumor tissue from 31 of 40 (>75%) patients examined. Overexpression of
TRPM8
was independent of changes in androgen receptor (AR) mRNA levels in tumor tissue. However, in studies with established cell lines,
TRPM8
expression was detectable only in AR-positive, but not in AR-negative cells, and it was suppressed by steroid deprivation or anti-androgen bicalutamide (Casodex) treatment, suggesting the requirement of AR activity for
TRPM8
expression in
prostate cancer
cells.
TRPM8
mRNA was also detected in body fluids of men. Most importantly, its levels were significantly higher (p<0.001, n=18) in urine and blood of patients with metastatic disease than in those of healthy men. However, there was no significant difference (p>0.05, n=10) in its levels between
prostate cancer
patients with localized disease and healthy men. Together, these studies demonstrate that
TRPM8
expression is androgen regulated in
prostate cancer
cells and that, while tissue
TRPM8
mRNA levels can be used for detection of
prostate cancer
, urine and blood
TRPM8
mRNA levels may prove to be useful for distinguishing metastatic disease from clinically localized
prostate cancer
at the time of diagnosis.
...
PMID:Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids. 2004 80
Prostate cancer
(PC) is a major health problem in adult males.
TRPM8
, a cationic TRP channel activated by cooling and menthol is upregulated in PC. However, the precise role of
TRPM8
in PC is still unclear. Some studies hypothesized that
TRPM8
-mediated transmembrane Ca(2+) fluxes play a key role in cellular proliferation of PC cells. In contrast, other findings suggest that high
TRPM8
levels may reduce the metastatic potential of PC cells. A detailed understanding of the response of
TRPM8
channels to pharmacological modulators of their activity is relevant when considering potential therapies, targeting this ion channel to treat PC. We characterized the pharmacological and functional properties of native
TRPM8
channels in four human prostate cell lines, PNT1A, LNCaP, DU145, and PC3, commonly used as experimental models of PC. PNT1A is a non-tumoral prostate cell line while the other three correspond to different stages of PC. Here, we show that cold- and agonist-evoked [Ca(2+)](i) responses in PC cells are much less sensitive to well-characterized agonists (menthol and icilin) and antagonists (BCTC, clotrimazole, and DD01050) of
TRPM8
channels, compared to
TRPM8
channels in other tissues, suggesting a different molecular composition and/or spatial organization. In addition, the forced overexpression of human
TRPM8
facilitated the trafficking of
TRPM8
channels residing in the endoplasmic reticulum to the plasma membrane, leading to a marked potentiation in the efficacy of the different blockers. These results predict that blockers of canonical
TRPM8
channels may be less effective in halting proliferation of PC cells than expected.
...
PMID:Pharmacological and functional properties of TRPM8 channels in prostate tumor cells. 2105 13
1
2
3
4
Next >>